{
  "id": "0aa8bdb418cc88f2",
  "title": "Ficerafusp Alfa 2000mg Q2W Demonstrates Deep , Durable Responses in 1L R / M HPV - Negative HNSCC and Supports Development of Less Frequent Dosing Regimen",
  "description": "20260219T223000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/02/20/tmt-newswire/globenewswire/ficerafusp-alfa-2000mg-q2w-demonstrates-deep-durable-responses-in-1l-rm-hpv-negative-hnscc-and-supports-development-of-less-frequent-dosing-regimen/2281600",
  "published_at": "20260219T223000Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/02/20/tmt-newswire/globenewswire/ficerafusp-alfa-2000mg-q2w-demonstrates-deep-durable-responses-in-1l-rm-hpv-negative-hnscc-and-supports-development-of-less-frequent-dosing-regimen/2281600",
    "url_mobile": "https://www.manilatimes.net/2026/02/20/tmt-newswire/globenewswire/ficerafusp-alfa-2000mg-q2w-demonstrates-deep-durable-responses-in-1l-rm-hpv-negative-hnscc-and-supports-development-of-less-frequent-dosing-regimen/2281600/amp",
    "title": "Ficerafusp Alfa 2000mg Q2W Demonstrates Deep , Durable Responses in 1L R / M HPV - Negative HNSCC and Supports Development of Less Frequent Dosing Regimen",
    "seendate": "20260219T223000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/20/944325.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}